QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $152,000 | +2.7% | 5,410 | 0.0% | 0.00% | – |
| Q3 2016 | $148,000 | +25.4% | 5,410 | 0.0% | 0.00% | – |
| Q2 2016 | $118,000 | -32.2% | 5,410 | -30.4% | 0.00% | – |
| Q1 2016 | $174,000 | -19.1% | 7,771 | 0.0% | 0.00% | – |
| Q4 2015 | $215,000 | +7.5% | 7,771 | 0.0% | 0.00% | – |
| Q3 2015 | $200,000 | +7.5% | 7,771 | +3.3% | 0.00% | – |
| Q2 2015 | $186,000 | -2.1% | 7,523 | 0.0% | 0.00% | – |
| Q1 2015 | $190,000 | +3.8% | 7,523 | -3.6% | 0.00% | – |
| Q4 2014 | $183,000 | +2.8% | 7,807 | 0.0% | 0.00% | – |
| Q3 2014 | $178,000 | -6.8% | 7,807 | 0.0% | 0.00% | – |
| Q2 2014 | $191,000 | -0.5% | 7,807 | -14.0% | 0.00% | – |
| Q1 2014 | $192,000 | +3.2% | 9,076 | +16.3% | 0.00% | – |
| Q4 2013 | $186,000 | +7.5% | 7,803 | -3.4% | 0.00% | – |
| Q3 2013 | $173,000 | +7.5% | 8,078 | 0.0% | 0.00% | – |
| Q2 2013 | $161,000 | – | 8,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 630,990 | $17,371,542,000 | 5.45% |
| Tikvah Management LLC | 369,425 | $10,137,000 | 5.29% |
| Hardman Johnston Global Advisors LLC | 3,786,208 | $103,894,000 | 4.73% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 300,000 | $8,232,000 | 4.50% |
| HealthCor Management, L.P. | 2,275,000 | $62,426,000 | 3.80% |
| Opus Point Partners Management, LLC | 110,565 | $3,034,000 | 1.70% |
| Douglas Lane & Associates, LLC | 1,847,676 | $50,700,000 | 1.35% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,854,629 | $78,331,000 | 1.20% |
| C M BIDWELL & ASSOCIATES LTD | 144,340 | $3,961,000 | 0.94% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,471,580 | $40,380,000 | 0.94% |